View in EDS HTML Full Text PDF Full Text

Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.

Saved in:
Bibliographic Details
Title: Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.
Authors: Ng SC; Department of Haematology, Subang Jaya Medical Centre, Subang Jaya, Malaysia., Moon JH; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea., Park SS; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea., Koh Y; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea., Lee JH; Department of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea., Eom HS; Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea., Shin HJ; Department of Internal Medicine, Pusan National University Hospital, Pusan, Republic of Korea., Jung SH; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea., Do YR; Division of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea., Wilfred G; Department of Medicine, Hospital Queen Elizabeth, Kota Kinabalu, Malaysia., Husin A; Department of Internal Medicine, Universiti Sains Malaysia, Gelugor, Malaysia., Kim HJ; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea., Abdul Wahid S; Pusat Terapi Sel, Hospital Canselor Tuanku Muhriz, Kuala Lumpur, Malaysia., Lee MW; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea., Heo HW; Medical Affairs, Takeda Pharmaceuticals Korea Co. Ltd, Seoul, Republic of Korea., Kim K; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. kihyunkimk@gmail.com., Chuncharunee S; Department of Internal Medicine, Ramathibodi Hospital, Bangkok, Thailand. supornch@gmail.com.
Source: International journal of hematology [Int J Hematol] 2025 May; Vol. 121 (5), pp. 670-683. Date of Electronic Publication: 2025 Mar 20.
Publication Type: Journal Article; Multicenter Study; Observational Study
Journal Info: Publisher: Springer Japan Country of Publication: Japan NLM ID: 9111627 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1865-3774 (Electronic) Linking ISSN: 09255710 NLM ISO Abbreviation: Int J Hematol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40111640
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Ng+SC%22">Ng SC</searchLink>; Department of Haematology, Subang Jaya Medical Centre, Subang Jaya, Malaysia.<br /><searchLink fieldCode="AU" term="%22Moon+JH%22">Moon JH</searchLink>; Department of Hematology-Oncology, Kyungpook National University Hospital, School of Medicine, Kyungpook National University, Daegu, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Park+SS%22">Park SS</searchLink>; Department of Hematology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Koh+Y%22">Koh Y</searchLink>; Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Lee+JH%22">Lee JH</searchLink>; Department of Hematology-Oncology, Department of Internal Medicine, Dong-A University College of Medicine, Busan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Eom+HS%22">Eom HS</searchLink>; Center for Hematologic Malignancy, National Cancer Center, Goyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Shin+HJ%22">Shin HJ</searchLink>; Department of Internal Medicine, Pusan National University Hospital, Pusan, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Jung+SH%22">Jung SH</searchLink>; Department of Hematology-Oncology, Chonnam National University Hwasun Hospital, Hwasun, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Do+YR%22">Do YR</searchLink>; Division of Hemato-Oncology, Keimyung University Dongsan Medical Center, Daegu, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Wilfred+G%22">Wilfred G</searchLink>; Department of Medicine, Hospital Queen Elizabeth, Kota Kinabalu, Malaysia.<br /><searchLink fieldCode="AU" term="%22Husin+A%22">Husin A</searchLink>; Department of Internal Medicine, Universiti Sains Malaysia, Gelugor, Malaysia.<br /><searchLink fieldCode="AU" term="%22Kim+HJ%22">Kim HJ</searchLink>; Department of Internal Medicine, Hallym University Sacred Heart Hospital, Anyang, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Abdul+Wahid+S%22">Abdul Wahid S</searchLink>; Pusat Terapi Sel, Hospital Canselor Tuanku Muhriz, Kuala Lumpur, Malaysia.<br /><searchLink fieldCode="AU" term="%22Lee+MW%22">Lee MW</searchLink>; Department of Internal Medicine, Chungnam National University Hospital, Daejeon, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Heo+HW%22">Heo HW</searchLink>; Medical Affairs, Takeda Pharmaceuticals Korea Co. Ltd, Seoul, Republic of Korea.<br /><searchLink fieldCode="AU" term="%22Kim+K%22">Kim K</searchLink>; Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea. kihyunkimk@gmail.com.<br /><searchLink fieldCode="AU" term="%22Chuncharunee+S%22">Chuncharunee S</searchLink>; Department of Internal Medicine, Ramathibodi Hospital, Bangkok, Thailand. supornch@gmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229111627%22">International journal of hematology</searchLink> [Int J Hematol] 2025 May; Vol. 121 (5), pp. 670-683. <i>Date of Electronic Publication: </i>2025 Mar 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Multicenter Study; Observational Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Springer+Japan%22">Springer Japan </searchLink><i>Country of Publication: </i>Japan <i>NLM ID: </i>9111627 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1865-3774 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2209255710%22">09255710 </searchLink><i>NLM ISO Abbreviation: </i>Int J Hematol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40111640
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s12185-025-03927-z
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 670
    Titles:
      – TitleFull: Real-world effectiveness of ixazomib, lenalidomide and dexamethasone in Asians with relapsed/refractory multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Ng SC
      – PersonEntity:
          Name:
            NameFull: Moon JH
      – PersonEntity:
          Name:
            NameFull: Park SS
      – PersonEntity:
          Name:
            NameFull: Koh Y
      – PersonEntity:
          Name:
            NameFull: Lee JH
      – PersonEntity:
          Name:
            NameFull: Eom HS
      – PersonEntity:
          Name:
            NameFull: Shin HJ
      – PersonEntity:
          Name:
            NameFull: Jung SH
      – PersonEntity:
          Name:
            NameFull: Do YR
      – PersonEntity:
          Name:
            NameFull: Wilfred G
      – PersonEntity:
          Name:
            NameFull: Husin A
      – PersonEntity:
          Name:
            NameFull: Kim HJ
      – PersonEntity:
          Name:
            NameFull: Abdul Wahid S
      – PersonEntity:
          Name:
            NameFull: Lee MW
      – PersonEntity:
          Name:
            NameFull: Heo HW
      – PersonEntity:
          Name:
            NameFull: Kim K
      – PersonEntity:
          Name:
            NameFull: Chuncharunee S
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2025 May
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 1865-3774
          Numbering:
            – Type: volume
              Value: 121
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: International journal of hematology
              Type: main
ResultId 1